Our company has been very active over the last two years in this area, and proof of this are the different agreements with different companies to distribute their products:
|2007||Acquisition of Reutenox® (Tenixicam) to Solvay Pharma, to reinforce rheumatology portfolio|
|2010||Signature of Non-Exclusive Distribution Agreement with Alere for the commercialization of Actim Prom® & Actim Partus® in Spain, medical device test for detection of Fetal Membrane Rupture in Gynecology.|
Signature of Exclusive Distribution Agreement with Lenus Pharma for the commercialization in Spain of Profertil® , vital substances in support of male fertility.
Signature of Exclusive Distribution Agreement with Polichem for the commercialization in Spain of Elastolabo® , gel to reduce the risk of perineal tears or need for episiotomy during childbirth.
Signature of Exclusive Distribution Agreement with Vital Access for the commercialization in Spain of Venous Window Neddle Guide (VWNGTM), is indicated for use as an access device accessory on arteriovenous fistulas (AVF) for hemodialysis procedures using a constant site or “buttonhole” method of needle insertion.
Signature of Exclusive Distribution Agreement with Emodial for the commercialization in Spain of Dressings for Dialysis.
|Therapeutic focus||Central nervous system, rheumatology, nephrology, urology, gynecology and oncology-radiation therapy.|
|Product Type||Prescription and OTC drugs, food supplements, healthcare products, medical devices and product for diagnostics.|
What we offer
- Commercial expertise in the Spanish healthcare market for medical specialists (pharmaceuticals, medical devices and food supplements.
- Experience in the introduction of new products and therapies in highly specialized therapeutic areas.
- Close collaboration with scientific associations and opinion leaders.
- Experience in and Regulatory Affaires in the EU.